Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

DNTHDNTH
10 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in DIANTHUS THERAPEUTICS INC

No. RA Capital Management exited its DNTH (Dianthus Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 2,611,733 shares worth $219.2M. RA Capital Management first reported DNTH in Q1 2024 and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$70M

Total Shares Change

-2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$97.48
0
2026-Q1
Increased
2.6M
+62.0%
$219.2M2.3%$55.39
76
2025-Q4
Decreased
1.6M
-43.8%
$66.4M0.7%$40.96
0
2025-Q3
Unchanged
2.9M
0.0%
$112.8M1.4%$39.55
0
2025-Q2
Unchanged
2.9M
0.0%
$53.4M0.9%$17.63
0
2025-Q1
Increased
2.9M
+53.6%
$52M0.9%$19.99
58
2024-Q4
Decreased
1.9M
-20.0%
$40.7M0.5%$21.50
0
2024-Q3
Unchanged
2.3M
0.0%
$63.9M0.7%$27.24
0
2024-Q2
Unchanged
2.3M
0.0%
$60.4M0.8%$25.88
0
2024-Q1
New
2.3M
-
$70M0.9%$30.00
58

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used